FASCINATION ABOUT JAK3-IN-1

Distribution: Zafirlukast demonstrates an intensive plasma protein binding charge of 99%. The drug mostly binds to albumin.Zafirlukast inhibits bronchoconstriction triggered by many different types of inhalational challenges. Administration of zafirlukast as a pretreatment properly mitigated bronchoconstriction induced by cold air and sulfur dioxid